Amylyx Pharmaceuticals, Inc. (AMLX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US03237H1014
Amylyx Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Gross profit | 0.00 USD |
| Operating income | -153.29 m USD |
| EBIT | -153.99 m USD |
| Net income | -144.74 m USD |
| Diluted EPS – continuing operations | -1.53 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Further, it develops AMX0318, a GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseaees. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
More stocks
- Guangdong Aofei Data Technology Co Ltd Class A (300738.SZ)
- RH (RH)
- Ningbo Sanxing Medical Electric Co Ltd (601567.SS)
- Liberty Global Ltd. (LBTYK)
- Hyundai Steel (004020.KS)
- Lao Feng Xiang Co Ltd A (600612.SS)
- Hubei Xinyangfeng Fertilizer Co Ltd (000902.SZ)
- Yongan Futures Co.Ltd. (600927.SS)
- Zhejiang Huace Film TV Co (300133.SZ)
- Anima Holding SpA (ANIM.MI)
- Soc Indust Financiere Artois SA (ARTO.PA)
- FEDERAL HOME LOAN MORTGAGE CORP (FMCC)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.